跳到正文
制药经理人· GxP知识岛·· 7 天前AI 评分68

FDA 公布青岛康原药业483检查报告:2016年4月检查列11项观察

FDA 483:山东青岛康原药业有限公司

AI 导读

FDA 公布青岛康原药业有限公司原料药厂的483检查报告,该次检查于2016年4月18日至22日进行,共列11项观察,签发日期为2016年4月22日。

正文

近日,FDA 公布了青岛康原药业有限公司(青岛胶州市营海工业园3号,FEI 3006512854)的483检查报告,检查5天,列11项观察。

第1项就是回头看。2013年1月25日那次检查发现,产品杂质谱没有研究方案;企业在2013年3月1日的回复里说,一两个月内会向 FDA 提交方案草案。这次检查中,企业只拿出一些草稿数据,而且不是英文;英文的结论性杂质总结仍然拿不出来。截至检查当日,企业称杂质研究仍在进行中,尚未向 FDA 提交任何回复。

第3项是另一条线:D 级洁净区的空调(ID #SC-KTJ-12-01)在停产时被关掉,停产期间只为 (b)(4) 开机。该系统上一次再确认是2015年7月12日,但关机状态——以及只在停产时开机 (b)(4) 的情况下——确认状态如何,企业没有提供任何数据。

天平占了五项:仓库地上放着电子天平(ID #SC-DZC-17-04)和装砝码的容器;称量间的秤(ID #SC-DZC-17-06)校准用的砝码量程不覆盖实际称量范围;称量记录表(03-103-A1 02)上不记每种物料的实际重量,表格本身也丢在地上;而管秤的 SOP 03-103 只写了“放在清洁干燥的环境”,对放在哪、搬动后要不要再校准,一个字没有。

Inspection Details

检查基本信息

Firm / 企业

Qingdao Kangyuan Pharmaceutical Co., Ltd. 青岛康原药业有限公司

Address / 地址

No. 3 Yinghai Industrial Area, Jiaozhou City(胶州市营海工业园3号)

City / 城市

Qingdao 266300, China(中国青岛,266300)

FEI Number / FEI 号

3006512854

Dates of Inspection / 检查日期

2016年4月18日–4月22日

Type Establishment Inspected / 受检设施类型

API Manufacturer(原料药生产商)

Issued To / 收件人

Naishan (NMI) Liu, Chairman & Founder(刘乃山,董事长、创始人)

District Office / 地区办公室

CDER/OC/OMQP/DIDQ, HFD-325, 10903 New Hampshire Ave., Bldg 51, Rm 4225, Silver Spring, MD 20993(电话 +1-301-796-3334,传真 1-301-847-8738)

Issued / 签发

2016年4月22日 检查员:Debra I. Love;Saied A. Asbahy(两人职称均为 Investigator)

说明:原件为连续编号的11项观察,没有观察标题,也没有印法规条款号。本稿各观察的标题与括号内的条款号,均为编者按内容所作对应,见文末译注①。

OBSERVATION 1

观察1:三年前承诺的杂质研究仍是草稿(211.160(b))

During the previous inspection on 1/25/2013, it was found that no study protocol had been generated for impurity profile characterization of (b)(4) It had been stated in the firm's response of 3/1/2013 that a draft protocol would be submitted to the FDA in 1-2 months. During the current inspection, although your firm presented some draft data (not in English), but your firm did not produce a conclusive impurity summary results in English. Further, your firm stated that as of that date, no response has been submitted to the FDA as the impurity studies are still in-progress.

2013年1月25日的前次检查发现,(b)(4) 的杂质谱表征没有研究方案。企业在2013年3月1日的回复中称,将在1至2个月内向 FDA 提交一份方案草案。本次检查中,企业虽然出示了一些草稿数据(且不是英文),但拿不出英文的结论性杂质总结。此外,企业称截至检查当日,由于杂质研究仍在进行中,尚未向 FDA 提交任何回复。

OBSERVATION 2

观察2:同类仪器的结果差异未作确认(211.160(b))

During the previous inspection on 1/25/2013, it was found that the (b)(4) results from the (b)(4) (b)(4) were noticeably different (b)(4) According to your firm's response, these different (b)(4) are within range and do not impact the product quality. According to our conversation, you have added another (b)(4) but none of these (b)(4) have been qualified to assure that its (b)(4) is accurate, precise, linear, and robust.

2013年1月25日的前次检查发现,不同 (b)(4) 上 (b)(4) 所得的结果存在明显差异。按企业的回复,这些差异在范围内,不影响产品质量。据本次交谈,企业又增加了另一台 (b)(4),但这些 (b)(4) 中没有一台经过确认,无法保证其 (b)(4) 准确、精密、线性且耐用。

OBSERVATION 3

观察3:D级洁净区停产就把空调关掉(211.46(b))

During our walkthrough of the Building (b)(4) which is used for (b)(4) API production, your firm explained that the HVAC, ID #SC-KTJ-12-01, for clean rooms class D is powered off during non-operation. It was further explained that the HVAC power is turned on for (b)(4) during non-operation. Since the HVAC system is re-qualified (b)(4) and was last re-qualified on 7/12/2015, no data was presented as to its qualification status when the system is powered off and only powered on for (b)(4) during non-operation.

在巡查用于 (b)(4) 原料药生产的 (b)(4) 楼时,企业解释说,D 级洁净区的空调(HVAC,ID #SC-KTJ-12-01)在停产期间是关掉的;并进一步说明,停产期间只为 (b)(4) 开机。该系统按 (b)(4) 再确认,上一次再确认是2015年7月12日;但系统处于关机状态、停产期间只开机 (b)(4) 的情况下,其确认状态如何,企业没有提供任何数据。

OBSERVATION 4

观察4:更换件没有更换频次(211.67(a))

The firm explained that the (b)(4) used during (b)(4) step is replaced according to the manufacturer (b)(4). Since the qualification of the (b)(4), none of the (b)(4) replacement frequencies are specified in the maintenance schedule and it is unclear how the replacement will occur in the batch record instructions.

企业解释说,(b)(4) 工序中使用的 (b)(4) 按制造商 (b)(4) 更换。但自 (b)(4) 确认以来,维护计划中没有规定任何一项 (b)(4) 的更换频次,批记录指令中也没有说明更换如何执行。(原件此句在脱敏后不完整,本稿照录。)

OBSERVATION 5

观察5:水系统没有监测(211.63)

The (b)(4) of the (b)(4) water system is not monitored and no (b)(4) are installed throughout the system. There is no (b)(4) indication of the (b)(4) water distribution tank and the loop system to the building (b)(4) workshop.

(b)(4) 水系统的 (b)(4) 未进行监测,整个系统也没有安装 (b)(4)。(b)(4) 水分配罐以及通往 (b)(4) 车间的回路,没有 (b)(4) 指示。

OBSERVATION 6

观察6:粗品阶段没有保持时间数据(211.111)

The firm has conducted bulk hold-time studies for the (b)(4) operations. The firm, however, did not produce bulk hold-time data for the (b)(4) crude (b)(4) stages of the (b)(4) production.

企业已就 (b)(4) 操作做过 bulk hold-time(中间品保持时间)研究。但是,(b)(4) 生产中粗品 (b)(4) 阶段没有提供保持时间数据。

OBSERVATION 7

观察7:天平校准量程不覆盖称量范围(211.68(a))

The scale, ID # SC-DZC-17-06, which is used in the (b)(4) room, is (b)(4) calibrated using a (b)(4) standard weight. However the scale weighing range is between (b)(4) to (b)(4). In addition the vendor calibration certificate dated (b)(4) did not indicate that the scale had been calibrated within the scale weighing range. The scale (b)(4) calibration does not cover the stated scale weighing range.

称量间使用的秤(ID # SC-DZC-17-06),是用 (b)(4) 标准砝码以 (b)(4) 方式校准的。但该秤的称量范围在 (b)(4) 至 (b)(4) 之间。此外,日期为 (b)(4) 的供应商校准证书未表明该秤是在其称量范围内完成校准的。该秤的 (b)(4) 校准不覆盖其所标示的称量范围。

OBSERVATION 8

观察8:天平与砝码放在仓库地上(211.67(a))

On 4/18/16, we observed an electrical balance, ID # SC-DZC-17-04, and a container housing a (b)(4) reference weight, ID # SC-DZC-17-04, sitting on the floor of the (b)(4) Warehouse (b)(4) which may be subject to contamination and instability. The balance is used to check the weight of incoming (b)(4) raw materials after receipt by the warehouse.

2016年4月18日观察到,一台电子天平(ID # SC-DZC-17-04)以及一个装 (b)(4) 基准砝码的容器(ID # SC-DZC-17-04),直接放在 (b)(4) 仓库的地面上,可能受到污染、也可能不稳定。该天平用于仓库收货后核对进厂 (b)(4) 原料的重量。

OBSERVATION 9

观察9:称量记录不记实际重量(211.100(b))

On 4/18/16, we observed an attachment form, titled "Balance using records 03-103-A1 02", which was used to record the weight of (b)(4) materials, (b)(4) Crude, on 4/2/16. The actual weight of each material is not recorded on the form. This form was found sitting on the floor of the (b)(4) Warehouse (b)(4) next to the electrical balance, ID # SC-DZC-17-04, and a container housing a (b)(4) reference weight, ID # SC-DZC-17-04.

2016年4月18日观察到一份附表,题为“Balance using records 03-103-A1 02”,用于记录2016年4月2日 (b)(4) 物料((b)(4) 粗品)的称量。表上没有记录每种物料的实际重量。这份表就被放在 (b)(4) 仓库的地上,挨着电子天平(ID # SC-DZC-17-04)和装 (b)(4) 基准砝码的容器。

图2 原件第2页:第5至10项(水系统、粗品保持时间、天平与称量记录)

OBSERVATION 10

观察10:SOP 没说天平该放哪、搬动后要再校准(211.100(a))

The written procedure, Gauge and Calibration Management, SOP 03-103, version 02, effective date 7/20/15, did not include adequate instructions regarding where a balance should be placed for weighing and measuring operations. This procedure only states to place the instrument in a clean and dry environment. The procedure also does not have instructions regarding re-calibration of a balance after it is moved.

书面程序《量具与校准管理》(SOP 03-103,第02版,生效日期2015年7月20日)未对天平在称量操作中应放置于何处作出适当规定。该程序只写了要把仪器放在清洁干燥的环境中。程序对天平搬动后是否需要重新校准,也没有规定。

OBSERVATION 11

观察11:楼外的 (b)(4) 站点里没有 (b)(4)(211.63)

On 4/20/16, during the walkthrough of the building (b)(4) Workshop, we observed (b)(4) stations situated on the exterior of the building which contained no (b)(4).

2016年4月20日,在巡查 (b)(4) 车间的楼栋时,看到设在楼外的 (b)(4) 站点,里面没有 (b)(4)。

图3 原件第3页:第10项续(SOP 03-103)与第11项

来源:制药经理人 · mp.weixin.qq.com

所属事件

查看事件全部
FDA公布青岛康原药业483,复盘指旧整改承诺未兑现